Abbonarsi

Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study - 13/09/23

Doi : 10.1016/j.ahj.2023.05.007 
Xenia Begun, MD a, , Jawad H. Butt, MD a, Søren L. Kristensen, MD, PhD a, Peter E. Weeke, MD, PhD a, Ole De Backer, MD, PhD a, Jarl E. Strange, MD a, Morten Schou, MD, DMSc b, Lars Køber, MD, DMSc a, Emil L. Fosbøl, MD, PhD a
a Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 
b Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark 

Reprint requests: Xenia Begun, MD, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.Department of CardiologyRigshospitaletCopenhagen University HospitalBlegdamsvej 9Copenhagen2100Denmark

Riassunto

Background

Valve-in-valve-transcatheter aortic valve implantation (TAVI) is a feasible and increasingly used treatment option for failed surgical aortic prosthesis, but data from clinical practice are limited. We aimed to examine patient characteristics and outcomes of patients undergoing TAVI in a surgival valve (valve-in-valve TAVI) compared with patients undergoing TAVI in a native valve.

Methods

Using nationwide registries, we identified all Danish citizens, who underwent TAVI from January 1, 2008, to December 31, 2020.

Results

A total of 6,070 patients undergoing TAVI were identified; 247 (4%) patients had a history of SAVR (The valve-in-valve cohort). The median age of the study population was 81 (25th-75th percentile 77-85) and 55% were men. Patients with valve-in-valve-TAVI were younger but had a greater burden of cardiovascular comorbidities compared with patients with native-valve-TAVI. Within 30 days post procedure, 11 (0.2%) and 748 (13.8%) patients who underwent valve-in-valve-TAVI and native-valve-TAVI, respectively, had a pacemaker implantation. The cumulative 30-day risk of death among patients with valve-in-valve-TAVI was 2.4% (95% CI: 1.0%-5.0%) and 2.7% (95% CI: 2.3%-3.1%) in patients with native-valve-TAVI, respectively. Correspondingly, the cumulative 5-year risk of death was 42.5% (95% CI: 34.2%-50.6%) and 44.8% (95% CI: 43.2%-46.4%), respectively. In multivariable Cox proportional hazard analysis, valve-in-valve-TAVI was not associated with a significantly different risk of death at 30 days (Hazard ratio (HR) = 0.95, 95% CI 0.41-2.19) and 5 years (HR = 0.79, 95% CI 0.62-1.00) post-TAVI compared with native-valve-TAVI.

Conclusions

TAVI in a failed surgical aortic prosthesis as compared to TAVI in a native valve, was not associated with significantly different short- and long-term mortality, suggesting that valve-in-valve-TAVI is a safe procedure.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : TAVI, SAVR, NOMESCO, ICD-8, ICD-10, HR, CI, CABG


Mappa


 Tweet: TAVI in a failed surgical aortic prosthesis as compared to TAVI in a native valve, was not associated with significantly different short- and long-term mortality.
 This paper was handled by Guest Editor: Blase Carabello, MD.


© 2023  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 264

P. 183-189 - ottobre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?
  • Francesco Violi, Valentina Castellani, Danilo Menichelli, Pasquale Pignatelli, Daniele Pastori
| Articolo seguente Articolo seguente
  • Temporal Changes in Clinical Characteristics and Outcomes of Adults With Congenital Heart Disease
  • Alexander C. Egbe, William R. Miranda, C. Charles Jain, Elizabeth H. Stephens, Kartik Andi, Omar Abozied, Heidi M. Connolly

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.